Skip to content

Smoking Cessation in Groups and With Tobacco Pastils

Phase 2 Study of Smoke Free Tobacco and Group Support for Smoking Cessation

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00265460
Enrollment
240
Registered
2005-12-14
Start date
2005-03-31
Completion date
2006-11-30
Last updated
2009-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

smoking cessation,, nicotine,, smokeless tobacco,, cigarettes

Brief summary

The purpose of this trial is to examine if smokeless tobacco combined with group support might increase smoking cessation rate compared with groups support in smokers.

Detailed description

The purpose of this trial is to examine if smokeless tobacco (Oliwer Twist) combined with group support (15-20 per group) might increase smoking cessation rate compared with groups support cold turkey in smokers.The test product should be used for 7 weeks. Seven group meetings are planned during the first 3 months followed bu follow-up sessions after 6 and 12 months. The design is open, randomized. Assessment of ECG, blood pressure, body-weight, carbon monoxide,lung function, stress, quality of life,withdrawal symptoms,adverse events and plasma nicotine, cotinine and thiocyante at entry and after 4 weeks etc.

Interventions

DRUGOliwer Twist smokeless tobacco (tobacco)

Sponsors

University Hospital, Gentofte, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* smoking \> 13 cigarettes/day * healthy (allowed: hypertension, diabetes type 2, mild asthma/COPD, hypercholesterolemia) * motivated for cessation * motivated to use tobacco pastils * motivated for group support

Exclusion criteria

* severe diseases * psychiatric diseases * using antipsychotic drugs * used NRT/bupropion in the last 3 months * consuming \> 6 drinks/day * pregnant/lactating * stopped smoking more than 2 days during last 3 months

Design outcomes

Primary

MeasureTime frame
Continuous Smoking cessation quit rate after 6 and 12 months

Secondary

MeasureTime frame
Side effects from tested tobacco product
Intake of nicotine and thiocyanate

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026